These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 8642283)

  • 1. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.
    Johnston JV; Malacko AR; Mizuno MT; McGowan P; Hellström I; Hellström KE; Marquardt H; Chen L
    J Exp Med; 1996 Mar; 183(3):791-800. PubMed ID: 8642283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia properties.
    Boyer MW; Vallera DA; Taylor PA; Gray GS; Katsanis E; Gorden K; Orchard PJ; Blazar BR
    Blood; 1997 May; 89(9):3477-85. PubMed ID: 9129056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
    Chen L; McGowan P; Ashe S; Johnston J; Li Y; Hellström I; Hellström KE
    J Exp Med; 1994 Feb; 179(2):523-32. PubMed ID: 7507508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes.
    Blake J; Johnston JV; Hellström KE; Marquardt H; Chen L
    J Exp Med; 1996 Jul; 184(1):121-30. PubMed ID: 8691125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
    Kim TS; Chung SW; Kim SH; Kang SN; Kang BY
    Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
    van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
    Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GD2 oligosaccharide: target for cytotoxic T lymphocytes.
    Zhao XJ; Cheung NK
    J Exp Med; 1995 Jul; 182(1):67-74. PubMed ID: 7540657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
    Harding FA; Allison JP
    J Exp Med; 1993 Jun; 177(6):1791-6. PubMed ID: 7684435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?
    Huang AY; Bruce AT; Pardoll DM; Levitsky HI
    J Exp Med; 1996 Mar; 183(3):769-76. PubMed ID: 8642281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells.
    Nakatsuka K; Sugiyama H; Nakagawa Y; Takahashi H
    J Hepatol; 1999 Jun; 30(6):1119-29. PubMed ID: 10406192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory.
    Suresh M; Whitmire JK; Harrington LE; Larsen CP; Pearson TC; Altman JD; Ahmed R
    J Immunol; 2001 Nov; 167(10):5565-73. PubMed ID: 11698427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation.
    Yang G; Hellström KE; Mizuno MT; Chen L
    J Immunol; 1995 Oct; 155(8):3897-903. PubMed ID: 7561096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
    J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation.
    Wang YC; Zhu L; McHugh R; Graham SD; Hillyer CD; Dillehay D; Sell KW; Selvaraj P
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):1-8. PubMed ID: 9147700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
    Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
    Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.
    Wolpert EZ; Petersson M; Chambers BJ; Sandberg JK; Kiessling R; Ljunggren HG; Kärre K
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11496-501. PubMed ID: 9326638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Hoskin DW
    J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.
    Jackaman C; Majewski D; Fox SA; Nowak AK; Nelson DJ
    Cancer Immunol Immunother; 2012 Dec; 61(12):2343-56. PubMed ID: 22714286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
    Ramarathinam L; Castle M; Wu Y; Liu Y
    J Exp Med; 1994 Apr; 179(4):1205-14. PubMed ID: 7511683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.